Paydirt
GG
Insider

G. Walmsley Graham

Director

G. Walmsley Graham (Director) filed 5 Form 4 reports in the past 24 months (3 purchases, 3 sales, 3 filed past the two-business-day deadline), most often in Olema Pharmaceuticals, Inc. (OLMA). The largest single filing was $9.6M of AKRO (200,000 sh × $48.00, as filed), executed Jan 30 2025. The median gap between execution and disclosure was 5 days.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
purchases not yet priced
Delay-adjustediThe same average, entered at disclosure dates
purchases not yet priced
Filings, ttm
5
3 buys · 3 sells · 3 late
Median delay
5d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$50.0M
shares × price, as filed
Last traded
Mar 27 2025
Filed Mar 27 2025

Median ADV $15.8M across their filed names

100% of their measured filings could not be priced (delisted or unquoted names). The returns above cover only what still trades.

Open performance
Volume by month
$17.4M$8.7M$0Oct 2024Apr 2025Oct 2025Apr 2026Nov 2024 · sells $17.4MDec 2024 · buys $4.7MDec 2024 · sells $9.5MFeb 2025 · buys $9.6MMar 2025 · buys $8.8M
Buys $23.1M Sells $26.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings Not on file 2 filings

Sector per market data · by filing · past 24 months

Most traded names
OLMA Olema Pharmaceuticals, Inc. OLMA · 1 buy · 3 sells 3 filings AKRO AKRO AKRO · 2 buys · 0 sells 2 filings
Recent filings
AKROPURCHASE Akero Therapeutics, Inc. View filing → $8.8M
200,000 sh across 3 lots
Exec Mar 25 2025
Filed Mar 27 2025 · 5:30 PM ET
AKROPURCHASE Akero Therapeutics, Inc. View filing → $9.6M
200,000 sh × $48.00
Exec Jan 30 2025
Filed Feb 7 2025 · 5:30 PM ET †
OLMASALE Olema Pharmaceuticals, Inc. View filing → $4.7M
700,761 sh × $6.75
Exec Dec 17 2024
Filed Dec 17 2024 · 5:30 PM ET
OLMASALE Olema Pharmaceuticals, Inc. View filing → $4.7M
700,761 sh × $6.75
Exec Dec 13 2024
Filed Dec 18 2024 · 5:30 PM ET †
OLMAPURCHASE Olema Pharmaceuticals, Inc. View filing → $4.7M
700,761 sh × $6.75
Exec Dec 13 2024
Filed Dec 18 2024 · 5:30 PM ET †
OLMASALE Olema Pharmaceuticals, Inc. View filing → $17.4M
1,175,000 sh across 2 lots
Exec Jun 4 2024
Filed Nov 26 2024 · 5:30 PM ET †